NCT07059143View on ClinicalTrials.gov

6 Weeks Right-Amygdala TIS for Depression

NAEnrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 27, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Major Depressive Disorder (MDD)
Interventions
DEVICE

Nervio-X

An 8-channel TIS device developed by NEURODOME Corporation.

Trial Locations (3)

Unknown

The Affiliated Brain Hospital Of Guangzhou Medical University, Guangdong

Ruijin Hospital, Shanghai

Anding Hospital (Mental Health Center of Tianjin Medical University), Tianjin

All Listed Sponsors
lead

Ruijin Hospital

OTHER